儿童慢性肾脏病-矿物质和骨异常诊疗循证指南(2024版)
该指南由中华医学会儿科学分会肾脏病学组发起,针对儿童CKD-MBD的诊治提出15个临床问题的推荐。指南结合儿童生长发育特点及多学科专家意见,旨在为CKD患儿提供兼顾生长需求的个体化治疗方案。
要点
- 儿童CKD-MBD普遍存在矿物质代谢和骨结构异常,需针对性管理。
- 既往儿童治疗多沿用成人方案,缺乏针对儿童特点的循证指导。
- 指南回答15个临床问题,强调个体化治疗兼顾生长发育需求。
核心结论
- 儿童CKD-MBD需基于生长发育特点进行个体化诊治,不能完全照搬成人指南。
研究设计与样本
- 由中华医学会儿科学分会肾脏病学组发起,联合成人、儿童肾脏、营养和药学专家制定,回答15个临床问题。
主要发现
- 儿童CKD患者普遍存在矿物质代谢和骨结构异常。
- 既往无专门针对儿童的CKD-MBD指南,临床实践多参考成人方案。
- 儿童处于生长发育期,用药范围与成人不同,新药已在儿童中验证。
临床怎么用
- 临床应参考该指南的15个临床问题推荐,结合患儿临床特征和治疗目标制定个体化方案。
- 治疗中需兼顾儿童的生长发育需求,不能简单套用成人指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) in children refers to the systemic mineral and bone metabolism disorders caused by CKD, including biochemical abnormalities, abnormalities in bone turnover, mineralization, quality, and ectopic calcification. Like the adult patients, mineral metabolism and bone structure abnormalities are universally present in children with CKD. But there have been no guidelines specifically for the children in the past. The medication treatment and clinical practices for children are usually based on those for adults, lacking targeted guidance. On the one hand, the children are in the process of growth and development, and the adult guidelines do not take into account the characteristics of children. On the other hand, the medication range for children is different from that of adults, and new drugs have been verified and tested in children. Hence, based on the developmental characteristics of children, combined with expert opinions from adults, children, kidney, nutrition, and medicine, this guideline was initiated by the Subspecialty Group of Nephrology, the Society of Pediatrics, Chinese Medical Association. It answered 15 important clinical questions related to the diagnosis and treatment of pediatric CKD-MBD, aimed to provide individualized treatment plans considering the clinical characteristics of CKD children and their treatment goals, while also addressing the needs of their growth and development.
引用
- Wang M, Xiong HY, Zhu C, et al. Evidence-Based Guidelines for the Diagnosis and Treatment of Pediatric CKD-Mineral and Bone Disorder (Version 2024). Kidney Int Rep. 2026. PMID: 42282145. doi:10.1016/j.ekir.2026.106492
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。